Tomas Philipson

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer
    Tomas Philipson
    Irving B Harris Graduate School of Public Policy Studies, University of Chicago, Illinois, USA
    Health Aff (Millwood) 31:667-75. 2012
  2. ncbi Infectious disease transmission and infection-dependent matching
    T Philipson
    Department of Economics, University of Chicago, IL 60637, USA
    Math Biosci 148:161-80. 1998
  3. ncbi The long-run growth in obesity as a function of technological change
    Tomas J Philipson
    Irving B Harris Graduate School of Public Policy Studies, Department of Economics, University of Chicago, 1155 East 60th Street, Chicago, IL 60637, USA
    Perspect Biol Med 46:S87-107. 2003
  4. ncbi Government perspective: food labeling
    Tomas Philipson
    The University of Chicago, Chicago, IL 60637, USA
    Am J Clin Nutr 82:262S-264S. 2005
  5. ncbi Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome
    Tomas J Philipson
    University of Chicago, IL 60637, USA
    Am J Manag Care 16:290-7. 2010
  6. ncbi Cost-effectiveness as a price control
    Anupam B Jena
    Department of Economics and School of Medicine, University of Chicago, Illinois, USA
    Health Aff (Millwood) 26:696-703. 2007
  7. ncbi Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Tomas J Philipson
    University of Chicago, USA
    AHIP Cover 47:29, 31, 33. 2006
  8. ncbi Cost-effectiveness analysis and innovation
    Anupam B Jena
    The University of Chicago, Chicago, IL, USA
    J Health Econ 27:1224-36. 2008
  9. ncbi Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates
    Ernst R Berndt
    Sloan School of Management, Massachusetts Institute of Technology, 50 Memorial Drive, E52 452, Cambridge, MA 02142, USA
    Nat Rev Drug Discov 4:545-54. 2005

Research Grants

  1. OLD AGE LONGEVITY AND THE MARKET FOR LONG TERM CARE
    Tomas Philipson; Fiscal Year: 2001

Detail Information

Publications9

  1. ncbi An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer
    Tomas Philipson
    Irving B Harris Graduate School of Public Policy Studies, University of Chicago, Illinois, USA
    Health Aff (Millwood) 31:667-75. 2012
    ..Our study suggests that the higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States...
  2. ncbi Infectious disease transmission and infection-dependent matching
    T Philipson
    Department of Economics, University of Chicago, IL 60637, USA
    Math Biosci 148:161-80. 1998
    ..Evidence in support of the economic type of infection-dependent matching is presented, by using data on the joint distribution of partners' HIV statuses in a random sample of couples from San Francisco in 1988-1989...
  3. ncbi The long-run growth in obesity as a function of technological change
    Tomas J Philipson
    Irving B Harris Graduate School of Public Policy Studies, Department of Economics, University of Chicago, 1155 East 60th Street, Chicago, IL 60637, USA
    Perspect Biol Med 46:S87-107. 2003
    ..We discuss the positive and normative impacts of direct and indirect public interventions to reduce obesity...
  4. ncbi Government perspective: food labeling
    Tomas Philipson
    The University of Chicago, Chicago, IL 60637, USA
    Am J Clin Nutr 82:262S-264S. 2005
    ..The Commissioner of the Food and Drug Administration has recently appointed an Obesity Working Group to develop proposals on pertinent topics of obesity, including the role of food labeling as a dietary guide...
  5. ncbi Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome
    Tomas J Philipson
    University of Chicago, IL 60637, USA
    Am J Manag Care 16:290-7. 2010
    ..To examine how cost sharing for prescription drugs affects compliance with antiplatelet therapy and subsequent health outcomes among patients with acute coronary syndrome (ACS)...
  6. ncbi Cost-effectiveness as a price control
    Anupam B Jena
    Department of Economics and School of Medicine, University of Chicago, Illinois, USA
    Health Aff (Millwood) 26:696-703. 2007
    ..Empirical evidence from a case study of HIV/AIDS provides an illustration of our conclusions...
  7. ncbi Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Tomas J Philipson
    University of Chicago, USA
    AHIP Cover 47:29, 31, 33. 2006
  8. ncbi Cost-effectiveness analysis and innovation
    Anupam B Jena
    The University of Chicago, Chicago, IL, USA
    J Health Econ 27:1224-36. 2008
    ..To the extent that such incentives are deemed either too low or too high compared to dynamically efficient levels, CE thresholds may be appropriately raised or lowered to improve dynamic efficiency...
  9. ncbi Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates
    Ernst R Berndt
    Sloan School of Management, Massachusetts Institute of Technology, 50 Memorial Drive, E52 452, Cambridge, MA 02142, USA
    Nat Rev Drug Discov 4:545-54. 2005
    ....

Research Grants2

  1. OLD AGE LONGEVITY AND THE MARKET FOR LONG TERM CARE
    Tomas Philipson; Fiscal Year: 2001
    ..Preliminary analysis of a subpart of the data that is to be collected more fully suggest that long-tenn care output contracts with male aging as predicted. ..